Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoChange Detected- Revision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page received a new site revision notice (Revision: v3.4.2) and an older notice (Revision: v3.4.1) was removed; these changes affect only site messaging and do not modify the study details, eligibility criteria, or data displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded a government-funding site status notice and updated the page version to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check65 days agoChange DetectedThe page now includes a glossary feature and a plain-language trial summary link (novctrd.com), with the revision updated to v3.4.0 and the latest QC submission dated 2026-01-26. The older QC date (2023-04-24) and No FEAR Act data entries were removed.SummaryDifference0.4%

- Check79 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. The study details and page structure remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.